ABBOTT LABORATORIES — Director's Dealing 2012

Mar 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-03-22

Reporting Person: Fussell Stephen R (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-22	Common shares without par value	M	1525	$33.2314	Acquired	101925	Direct
2012-03-22	Common shares without par value	M	5818	$47.82	Acquired	107743	Direct
2012-03-22	Common shares without par value	F	5948	$60.39	Disposed	101795	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-22	Option (right to buy)	$33.2314	M	1525	Disposed	2013-02-13	Common shares (1525)	Direct
2012-03-22	Option (right to buy)	$47.82	M	5818	Disposed	2013-02-13	Common shares (5818)	Direct
2012-03-22	Option (right to buy)	$60.39	A	5948	Acquired	2013-02-13	Common shares (5948)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	999	Indirect
Common shares without par value	53	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 21, 2012.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.